Evolution of the Average Target: Certara, Inc.

Evolution of the Average Target - Certara, Inc.

Evolution of the Target Price: Certara, Inc.

Evolution of the Target Price - Certara, Inc.

Changes in Analyst Recommendations: Certara, Inc.

2a778793fd501.jDuNhLkkSlwB1gq8jyAgV5-WwlEuwraUUt3TQkH3o4Y.xxbm3tgdDw1o5EbIwnlKGcjHpWReg-SjYJ_kEjWalc7oasXs7FEmHzbhOg~8ed54c549b38c1bb2b37e95b5fe4636e
09-30 UBS Downgrades Certara to Neutral From Buy, $10 Price Target MT
05-12 Morgan Stanley Cuts Price Target on Certara to $10 From $11, Keeps Equalweight Rating MT
02-27 Morgan Stanley Cuts Price Target on Certara to $11 From $12, Keeps Equalweight Rating MT
01-06 Certara Shares Rise After Upgrade From Leerink MT
01-06 Leerink Upgrades Certara to Outperform From Market Perform, Price Target is $13 MT
11-21 Rothschild & Co Redburn Initiates Coverage on Certara With Buy Rating, $10 Price Target MT
11-13 BMO Capital Initiates Certara at Market Perform MT
07/08/25 UBS Adjusts Price Target on Certara to $15 From $17.50, Maintains Buy Rating MT
27/02/25 TD Cowen Initiates Coverage on Certara With Buy Rating, $16 Price Target MT
27/09/24 Certara is Well-Positioned for Double-Digit Growth in Biosimulation Software Sales, UBS Says MT
27/09/24 UBS Upgrades Certara to Buy From Neutral, Price Target Remains $16 MT
09/08/24 Morgan Stanley Lowers Price Target on Certara to $16 From $21, Keeps Equalweight Rating MT
07/08/24 UBS Adjusts Certara Price Target to $16 From $20, Maintains Neutral Rating MT
11/07/24 KeyBanc Adjusts Price Target on Certara to $20 From $23, Maintains Overweight Rating MT
28/06/24 Barclays Lowers Price Target on Certara to $16 From $18, Maintains Equalweight Rating MT
10/04/24 Certara Poised to Benefit From Improving End Markets, KeyBanc Says MT
10/04/24 KeyBanc Upgrades Certara to Overweight From Sector Weight on Higher Conviction of Top-Line Trends, Sets $23 Price Target MT
04/04/24 JMP Securities Initiates Coverage on Certara With Market Perform Rating MT
01/03/24 UBS Raises Certara Price Target to $20 From $17, Maintains Neutral Rating MT
26/02/24 Leerink Partners Initiates Certara at Market Perform Rating With $19 Price Target MT
25/01/24 Barclays Adjusts Price Target on Certara to $18 From $16, Maintains Equal-Weight Rating MT
07/12/23 UBS Initiates Coverage on Certara With Neutral Rating, $17 Price Target MT
05/12/23 KeyBanc Initiates Certara at Sector Weight, Sees Current Valuation as 'Fair Given The More Muted End Markets' MT
20/10/23 BofA Securities Adjusts Price Target on Certara to $20 From $24, Maintains Buy Rating MT
22/08/23 Jefferies Downgrades Certara to Hold From Buy, Adjusts Price Target to $17 From $24.50 MT

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
-14.4%
+24.85%
+20.18%
+96.36%
+13.31%
+13.51%
+2.75%
+45.92%
+15.65%
+6.69%
Average +22.48%
Weighted average by Cap. +26.89%


Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
13
Last Close Price
10.71USD
Average target price
9.168USD
Spread / Average Target
-14.40%
High Price Target
12.00USD
Spread / Highest target
+12.04%
Low Price Target
7.000USD
Spread / Lowest Target
-34.64%

Analyst Consensus Detail

Analyst consensus - Certara, Inc.

Consensus revision (last 18 months)

Consensus revision (last 18 months) - Certara, Inc.
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
AA
MarketScreener Ratings - Certara, Inc.
  1. Stock Market
  2. Stocks
  3. CERT Stock
  4. Consensus Certara, Inc.